taletrectinib
innovent biologics,baoyuan biopharma,anheart therapeutics
['taletrectinib', 'innovent biologics', 'innovent bio', 'innovent']
anheart therapeutics and innovent biologics present updated phase 2 efficacy and safety data of taletrectinib (ros1 inhibitor) at asco 2022 
Pharmaceutical News - Direct Information